| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.58B | 60.37B | 56.36B | 54.22B | 49.94B | 48.55B |
| Gross Profit | 19.36B | 18.69B | 17.25B | 16.27B | 13.79B | 13.84B |
| EBITDA | 8.31B | 8.55B | 7.66B | 7.01B | 5.61B | 5.38B |
| Net Income | 5.79B | 5.49B | 4.86B | 4.47B | 3.50B | 3.28B |
Balance Sheet | ||||||
| Total Assets | 36.16B | 35.77B | 31.75B | 29.75B | 28.35B | 28.46B |
| Cash, Cash Equivalents and Short-Term Investments | 5.58B | 6.23B | 5.33B | 5.60B | 5.48B | 6.23B |
| Total Debt | 14.18B | 13.49B | 12.78B | 12.54B | 12.74B | 12.51B |
| Total Liabilities | 25.75B | 25.58B | 23.36B | 22.45B | 21.98B | 22.46B |
| Stockholders Equity | 10.40B | 10.19B | 8.39B | 7.30B | 6.36B | 6.00B |
Cash Flow | ||||||
| Free Cash Flow | 5.48B | 4.92B | 4.20B | 4.33B | 2.63B | 2.01B |
| Operating Cash Flow | 7.60B | 6.87B | 6.12B | 6.06B | 4.08B | 3.06B |
| Investing Cash Flow | -2.15B | -1.98B | -2.48B | -1.72B | -1.47B | -1.05B |
| Financing Cash Flow | -4.15B | -4.12B | -3.84B | -4.21B | -3.31B | -6.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $74.65B | 31.92 | 38.42% | 0.90% | 11.86% | 13.46% | |
80 Outperform | $171.28B | 29.93 | 59.66% | 1.07% | 8.06% | 21.36% | |
79 Outperform | $6.22B | 13.46 | 17.64% | ― | 11.23% | 8.96% | |
68 Neutral | $20.38B | 33.28 | 29.06% | ― | 10.60% | 19.47% | |
67 Neutral | $7.73B | 8.08 | 26.47% | 2.45% | 1.58% | 11.13% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $2.65B | 9.46 | 17.24% | 2.09% | 6.22% | 65.05% |